The 20 Best Posterior Fossa Tumor Doctors Near Me in Livingston, NJ

Joana S. Emmolo, MD is a board certified radiation oncologist at Atlantic Health System's Overlook Medical Center and CyberKnife Center. She is a member of various tumor boards for the Carol G. Simon Cancer Center and The Gerald J. Glasser Brain Tumor Center. Dr. Emmolo has a focus on brain tumors and breast cancer, with a special interest in accelerated and minimally invasive treatment options for both disease sites. She attended the University of Medicine and Dentistry of New Jersey in Newark, NJ and served as Chief Resident at New York Methodist Hospital in Brooklyn, NY. Dr. Emmolo speaks Spanish and Italian. In her free time, Dr. Emmolo enjoys spending time with her two young boys and travelling with family. Dr. Emmolo is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Radiation Induced Meningioma, Posterior Fossa Tumor, Meningioma, and Pleuropulmonary Blastoma. Dr. Emmolo is board certified in American Board Of Radiology. Dr. Emmolo is currently accepting new patients.

Joseph P. Weiner is a board-certified and fellowship-trained radiation oncologist at Atlantic Health System's Overlook Medical Center and CyberKnife Center. He is a member of various tumor boards for the Carol G. Simon Cancer Center. He is also the co-founder of the Prostate Cancer Multidisciplinary and Second Opinion Clinic at Overlook Medical Center. Dr. Weiner is an active member of the Gerald J. Glasser Brain Tumor Center as well.Dr. Weiner is trained to treat all oncologic conditions but has advanced fellowship training and a special interest in both prostate and brain tumors. He has published over 40 peer-reviewed articles on these topics, written numerous book chapters as well as given regional and national lectures at prominent oncologic conferences. Dr. Weiner was previously involved in the training of over 15 resident physicians to become attending Radiation Oncologists, as well as mentored numerous medical students seeking experience in oncology.Dr. Weiner has professional experience with multiple radiation delivery platforms, including fellowship training with the team that invented the CyberKnife Radiosurgery unit. He also has experience with gantry-based linear accelerators such as the Varian TrueBeam. He has previously worked with Proton Beam Therapy, both high-dose rate (HDR) and low-dose rate (LDR) Brachytherapy, and the Gamma Knife Radiosurgery unit. He is able to perform three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated arc therapy (VMAT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), and stereotactic body radiotherapy (SBRT). Dr. Weiner is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Radiation Induced Meningioma, Oligodendroglioma, and Prostatectomy. Dr. Weiner is board certified in American Board Of Radiology. Dr. Weiner is currently accepting new patients.

Dr. Yaron Moshel is recognized not only for his distinguished expertise but also for his warmth and patience, making him one of the most skilled and forward-thinking neurosurgeons in the field. His patient-centered approach—coupled with a commitment to pioneering new treatments and technologies—continues to revolutionize comprehensive brain tumor care, providing hope when it’s needed most.One of a select few neurosurgeons specializing in the removal of deep-seated benign and malignant brain and skull base tumors, Dr. Moshel integrates advanced techniques such as computer-guided navigation, awake surgery, intraoperative brain mapping, endoscopy, and microsurgery to achieve optimal outcomes. His expertise also includes 5-ALA fluorescent imaging and both open and minimally invasive skull base approaches, further enhancing precision and safety in complex neurosurgical procedures.A leader in innovation, he is at the forefront of Laser Interstitial Thermal Therapy (LITT), Fluorescent Brain Tumor Surgery, Brachytherapy, and Intracavitary Chemotherapy, expanding the possibilities for complex tumor treatment.Dr. Moshel plays a pivotal role in Atlantic Health’s CyberKnife® TrueBeam® program, contributing to the largest Stereotactic Radiosurgery Program in the tri-state region for brain tumor treatment. Actively engaged in research, he also participates in national multicenter clinical trials, driving advancements in the field. Dr. Moshel is rated as a Distinguished provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Meningioma, Glioma, Glioblastoma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Moshel is currently accepting new patients.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration. Dr. Strauss is board certified in American Board Of Internal Medicine. Dr. Strauss is currently accepting new patients.

Andy Rodriguez is a Neurologist practicing medicine in Livingston, New Jersey. He has been practicing medicine for over 18 years. Dr. Rodriguez is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Seizures, Memory Loss, Landau-Kleffner Syndrome, Autosomal Dominant Partial Epilepsy with Auditory Features, and Gastrostomy. Dr. Rodriguez is board certified in American Board Of Psychiatry And Neurology. Dr. Rodriguez is currently accepting new patients.

Eric Geller is a Neurologist practicing medicine in Livingston, New Jersey. Dr. Geller is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Seizures, Partial Familial Epilepsy, Epilepsy, Deep Brain Stimulation, and Gastrostomy. Dr. Geller is board certified in American Board Of Psychiatry And Neurology. Dr. Geller is currently accepting new patients.

Karleung Siu is a Hematologist and an Oncologist practicing medicine in Florham Park, New Jersey. Dr. Siu is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Siu is board certified in American Board Of Internal Medicine. Dr. Siu is currently accepting new patients.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Primitive Neuroectodermal Tumor (PNET).

Dr. Nicholas Metrus is a board-certified, fellowship-trained neurologist/neuro-oncologist with Atlantic Medical Group Neuroscience Associates and the Gerald J. Glasser Brain Tumor Center at Atlantic Health System. He is a specialist in the diagnosis and treatment of patients with brain tumors and conditions of the central nervous system. Dr. Metrus is part of a medical team that works together to provide exceptional personalized care for every patient using a multidisciplinary and comprehensive approach. His commitment to individualized care includes designing and overseeing each patient’s treatment plan, which can include any combination of chemotherapy, target therapy, and immunotherapy.Throughout his medical education, Dr. Metrus devoted his time to cutting-edge research and publishing his work on topics such as paraneoplastic disorders, tumefactive multiple sclerosis, and clinical trial enrollment, to name a few. He has also published book chapters on ependymomas and advances in clinical trial design for brain tumors. He pursed his fellowship training in neuro-oncology at MD Anderson Cancer Center, where he was the 2018 recipient of a research grant, the William James Miller Endowed Fellowship Award, for his work in Guillain Barre Syndrome following stem cell transplants, and again in 2019 for his description of unique presentations of cancer in the brain.His research on hypermutator gliomas has been presented at national and international medical conferences. Dr. Metrus earned his medical degree from the American University of the Caribbean and went on to complete his residency in neurology at the University of Texas Medical Branch. Dr. Metrus is a participating provider of the Atlantic Accountable Care Organization. Dr. Metrus is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Meningioma, Glioma, Oligodendroglioma, and Astrocytoma. Dr. Metrus is board certified in American Board Of Psychiatry And Neurology. Dr. Metrus is currently accepting new patients.

Dr. Frisoli is a highly skilled neurosurgeon whose expertise in brain tumor and skull base surgery makes him an invaluable asset to the Gerald J. Glasser Brain Tumor Center. With extensive fellowship training, he brings a wealth of specialized insight to the treatment of complex brain and skull base tumors, ensuring patients receive the most advanced, personalized care.Beyond his surgical precision, Dr. Frisoli is known for his unparalleled compassion, providing every patient with thoughtful, individualized care. His forward-thinking, meticulous approach allows him to deliver the safest, most effective treatments for even the most challenging brain and spine conditions.A leader in innovation, Dr. Frisoli is actively advancing the fields of minimally invasive spine surgery and state-of-the-art artificial disc replacement technology, continually pushing the boundaries of neurosurgical excellence. Dr. Frisoli is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pica, Posterior Fossa Tumor, Dysembryoplastic Neuroepithelial Tumors (DNET), Awake Craniotomy, and Thrombectomy. Dr. Frisoli is currently accepting new patients.

Dr. Brian Beyerl graduated Summa Cum Laude and was elected to Phi Beta Kappa while earning his Bachelor of Science degree from the University of Wisconsin–Madison. He went on to receive his medical degree from Johns Hopkins School of Medicine in Baltimore, Maryland. His post-graduate training included general surgery at Johns Hopkins Hospital and a neurosurgical residency at Massachusetts General Hospital, Harvard Medical School in Boston, Massachusetts. He became board-certified by the American Board of Neurological Surgery in 1990.Throughout his distinguished career as a brain tumor neurosurgeon, Dr. Beyerl co-directed the Atlantic Health Stereotactic Radiosurgery Program alongside Dr. Lou Schwartz. This pioneering program was the first in New Jersey to treat brain tumors with pinpoint radiation.Since retiring from active surgery in 2019, Dr. Beyerl has remained dedicated to patient care. As a Patient and Family Advocate at the Glasser Brain Tumor Center at Overlook Medical Center and Morristown Medical Center, he provides crucial support to brain tumor patients and their families. His role includes counseling, guidance on treatment transitions, and end-of-life care decisions, including hospice discussions.As a Permanent Deacon in the Catholic Church, Dr. Beyerl also offers spiritual support to those who seek it. He actively participates in monthly Brain Tumor Support and Caregiver Support Groups, ensuring that patients and families receive both medical guidance and emotional support throughout their journey. Dr. Beyerl is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Pallister-Hall Syndrome, Choroid Plexus Papilloma, Meningioma, and Radiation Induced Meningioma. Dr. Beyerl is currently accepting new patients.

James Liu is a Neurosurgery provider practicing medicine in Livingston, New Jersey. Dr. Liu is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Glomus Tympanum Tumor, Glomus Jugulare Tumor, Pituitary Tumor, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery. Dr. Liu is currently accepting new patients.

Nawal Shaikh is an Oncologist practicing medicine in Livingston, New Jersey. She has been practicing medicine for over 17 years. Dr. Shaikh is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioma, Neurofibromatosis, and Brain Tumor. Dr. Shaikh is currently accepting new patients.

David Huang is a Radiation Oncologist practicing medicine in Livingston, New Jersey. Dr. Huang is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Radiation Induced Meningioma, Posterior Fossa Tumor, and Primitive Neuroectodermal Tumor (PNET).

Usman Shah is a Hematologist and an Oncologist practicing medicine in Summit, New Jersey. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is board certified in American Board Of Internal Medicine. Dr. Shah is currently accepting new patients.

Dr. Markowski has been contributing to the field of oncology since working in a cancer research lab during and after his undergraduate work at Johns Hopkins University. A desire to care for patients brought him back to his home state of New Jersey where he completed his medical school degree at Rutgers-Robert Wood Johnson Hospital in New Brunswick, NJ. He then completed internal medicine residency and subsequent hematology/oncology fellowship training at Rutgers-Robert Wood Johnson Hospital/Cancer Institute of New Jersey.Throughout his hematology and oncology career Dr Markowski has published and presented many peer-reviewed articles, abstracts, and posters on a multitude of cancer types. He has particular interest and expertise in lung cancer, gastrointestinal cancers, and breast cancer. In addition, he has extensive experience taking care of patients with both benign and malignant blood disorders. Dr. Markowski is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Markowski is board certified in American Board Of Internal Medicine. Dr. Markowski is currently accepting new patients.

Jeffrey Politsky is a Neurologist practicing medicine in Morristown, New Jersey. Dr. Politsky is rated as an Advanced provider by MediFind in the treatment of Posterior Fossa Tumor. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Memory Loss, and Landau-Kleffner Syndrome. Dr. Politsky is board certified in American Board Of Psychiatry And Neurology. Dr. Politsky is currently accepting new patients.

Lorraine Lazar is a Neurologist and a Pediatric Neurologist practicing medicine in Morristown, New Jersey. Dr. Lazar is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Seizures, Landau-Kleffner Syndrome, Generalized Tonic-Clonic Seizure, and Memory Loss. Dr. Lazar is board certified in American Board Of Psychiatry And Neurology. Dr. Lazar is currently accepting new patients.

Dr. Bonni Lee Guerin is a hematologist/oncologist and director of the Breast Cancer Treatment and Prevention Program at Overlook Medical Center, Summit, NJ where she also serves as chair of the Breast Panel, the Multidisciplinary Breast Tumor Board and director of Oncology Education. She is the principal investigator of numerous clinical trials exploring new ways to incorporate the latest advances in the management of breast cancer. She is also actively involved in the delivery of highly-specialized immunotherapy, IL-2, for the treatment of melanoma and kidney cancer.As a medical oncologist with more than 20 years of experience, Dr. Guerin is dedicated to providing the most up to date, cutting edge treatment while looking at each of her patients as an individual. Her philosophy is one of collaboration, working with all members of the care team to provide the best outcome possible. Dr. Guerin believes that compassion and being a good listener, traits she learned from her mother, help tailor a treatment plan that reflects not only the highest order of medical care, but also one that uniquely reflects each and every patient. Dr. Guerin believes it is just as much about living well as it is living long.Dr. Guerin earned her M.D. at SUNY Stonybrook in 1988, continued her residency at Vanderbilt University in Nashville and completed her fellowship in oncology/hematology at University of California San Diego Cancer Center. She is board certified in clinical oncology and internal medicine.Since 2002, Dr. Guerin has served as chair of the Women’s Oncology Forum, Network for Oncology Communication and Research (NOCR) – a national organization. She is a diplomate of the American Society of Clinical Oncology (ASCO) and is a recipient of the Pfizer Award for Excellence in Biochemical Research and a Member of the Expert Panel Consensus Guidelines for Systemic Therapy of Metastatic Renal Cell Carcinoma. She has been named by Castle Connelly as one of NY/Metro Top Doctors for the last 10 years, as well as a Top Doctor for Women's Health. She has recently been honored by Curemonos, a New Jersey non-profit organization dedicated to supporting medically underserved women with breast cancer, and was the keynote speaker at the American Cancer Society Relay for Life in Chatham, NJ. Her interests are in breast cancer, hepatobiliary cancer and immunotherapy. Dr. Guerin is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Guerin is board certified in American Board Of Internal Medicine. Dr. Guerin is currently accepting new patients.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is rated as an Experienced provider by MediFind in the treatment of Posterior Fossa Tumor. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Early is board certified in American Board Of Internal Medicine. Dr. Early is currently accepting new patients.